Hoth Therapeutics, Inc. — Director's Dealing 2021

Feb 11, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2020-12-31

Reporting Person: Knie Robb (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-18	Common Stock	J	4	—	Acquired	808259	Direct

Footnotes

F1: On May 18, 2020, AIkido Pharma, Inc. ("AIkido") distributed shares of the Issuer's common stock on a pro rata basis to its stockholders of record as of April 30, 2020 (the "Record Date"). Stockholders of AIkido received 1 share of the Issuer's common stock for each 500 shares of AIkido common stock held by such stockholders as of the Record Date.